David Barthel Email & Phone Number

Jupiter, Florida, Us

.At Marizyme, my task is raising capital and aligning business priorities with limited resources in a publicly traded micro-cap medical device company needing FDA approval and a total business transformation. Early on I identified and partnered with an Investment Bank to raise capital and move through the Nasdaq uplisting process using my deep understanding of SEC regulations. I’ve focused on critical priorities and minimizing risk by building valuation drivers around a robust diversified product pipeline, CE-generated revenue, monetized data, a deep IP portfolio, and multiple channels . My persistent optimism has never been more evident than in partnering with investors, structuring the financing, fostering relationships, closing, and using the capital to increase shareholder value in an extremely difficult capital market. Nonetheless, I have transformed, advanced, and commercialized DuraGraft, an FDA-cleared and CE-marked storage and flushing solution for preventing vein graft failure during Coronary Bypass Graft Surgery. I ideated and executed visionary strategies, developing, and commercializing multiple platform technologies for cardiac surgery, fat grafting, and organ transplant. In addition, I raised capital leading to S-1 process completion and future up-listing to Nasdaq, driving current global revenue growth and establishing future commercial viability across multiple disciplines, strategic partners, and sales channels. Noteworthy, I’ve escalated shareholder value by aligning resources with revenue priorities, FDA clearance, manufacturing, US commercialization and clinical trials all while serving as a trusted advisor and SME to physicians, researchers, strategic partners, investment bankers and the Board. In future-forward action, I established a strategic clinical and utilization partnership for DuraGraft with HCA for 2025. As a final note, I doubled revenue growth with a targeted distribution plan and my vast network in Europe and Asia in one year.

Melville, Ny, Us

At Henry Schein, in the Brasseler Medical for the Orthopedic Surgical Medical Division, I directed international revenue, product management, and marketing across the globe. Most notably, I led the US market launch of the EZX Acetabular Cup removal system for hip revision surgery and established worldwide distribution partners, growing global revenue 8% in one year. I also developed and executed five new product launch plans in 2021, skyrocketing revenue $5M.

In this position, I led profitable growth with full P&L responsibility for the Southeast division of 77 managers with 11 product capital and disposable platforms for GI Health, a business unit of minimally invasive therapies group of $30B Medtronic PLC. I authored and executed aggressive business plans emphasizing 18% unit growth across 6 diagnostic and therapeutic product platforms and 5 capital product platforms. As a result, I finished FY 2018 at 101% total revenue to quota with 12% revenue growth over FY 2017. I also sourced and seated 17 new account managers in FY 2016 escalating revenue growth 10.5%. In the middle of my term, I led the division through a complete reorganization including new product platforms and top talented sales teams in 3 years. I also developed and directed a direct sales force, encompassing product platforms for Capsule Endoscopy, EUS, diagnosis for GERD and Reflux, and treatment of Barrett’s Esophagus and Liver Cancer. In more detail of my role, I also authored budgets, forecasts, and strategic finance plans, collaborating with Finance, Sales Operations, Organizational Development, Marketing, Reimbursement, Product Development, and the Commercial Leadership Team. I led double-digit growth with multi-product platforms for diagnostic and therapeutic GI Health and built a revenue growth foundation through a strategy of utilizing internal and external resources, clinical and business acumen, and a culture of teamwork, transparency, accountability, and overcommunication.

Before the acquisition of The SmartPill Corp. by Given, as President and CEO, I raised capital and built resources in line with a private start-up medical device company and single-handedly built the company without an initial product from start-up to concept through the sale of a revenue-generating business to Given. I catapulted from concept through design, prototypes, software development, clinical trials, FDA approvals (and CE approval in Europe), and CPT Code Reimbursement approval. I identified early-stage investors, including Venture Capitalists, Investment Banks, and Strategic Partners, structuring the finance for a positive ROI and closing on capital. As I founded the company, I recruited and hired Engineering, Sales, Marketing, and Quality, Regulatory, Operations and Reimbursement. executives. I developed a Quality Management System, Performance Management System, Design Control, and defined the clinical trial pathway to complete 3 multi-centered clinical trials. Remarkedly, I boosted revenue by 25% every year from product release forward and achieved $2.5M in revenue in 2012. I also raised $76M through multiple funding rounds (series A, B, C) from leading venture capital firms, including Psilos and Oxford Biosciences, sophisticated high-net-worth investors, and Kimberly Clark. I aligned limited resources with critical priorities and met early milestones to motivate and sustain momentum and raise additional capital. At Given, I expanded the profit and performance worldwide of the SmartPill product platform, led clinical trials and reimbursement, and managed the complete P&L in this Israeli-based technology company manufacturing and marketing diagnostic products disorders of the GI tract. One of my many achievements was developing the marketing strategy for global expansion, sales plans and channels, and use indications including for pediatrics. I launched new markets, opened and drove $2M of sales through the Pharma channel and grew revenue 10% in a year.

Master Of Business Administration - Mba, Business Administration And Management, General

Bachler Of Arts